AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28617530
Drug: Non-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment group (no folic acid and vitamin B12)
Trial: 3358819
Drug: Alcohol intervention
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intervention (mean serum ethanol concentration 93 mg/100 ml, S.D. 17)
Trial: 3050006
Drug: Dexamethasone therapy
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone therapy for 7 days
Trial: 31965678
Drug: Intralesional methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intralesional methotrexate (MTX) 2 mg/ml
Trial: 9358933
Drug: Cytotoxic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic treatment
Trial: 22005905
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of 0.5% hyperbaric bupivacaine combined with 2.5 μg sufentanil (Group II)
Trial: 12624696
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dolasetron orally plus 8 mg dexamethasone intravenously
Trial: 28791820
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of botulinum toxin type A (group II)
Trial: 9256142
Drug: Capsaicin cream
RxNorm normalized name: CAPSAICIN 0.1 g in 100 g TOPICAL CREAM [Capsaicin Cream]
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin cream
Trial: 16130506
Drug: Calcium salts
RxNorm normalized name: lonazolac calcium salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium salts and vitamin D3 supplements alone
Trial: 26347110
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin 25 mg patches for 2 days before, the day of, and 2 days after each chemotherapy infusion.
Trial: 19815876
Drug: Artesunate (AS)
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate (AS) at 0.5 mg/kg
Trial: 19815876
Drug: Artesunate (AS)
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate (AS) at 1 mg/kg
Trial: 7816517
Drug: Intravenous fructose
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous fructose (200 mg/kg, 20% solution, 2.5 min)
Trial: 24663049
Drug: Azacitidine (AZA)
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine (AZA) 50 mg/m²/d for 10 days
Trial: 24663049
Drug: Azacitidine (AZA)
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine (AZA) 50 mg/m²/d for 10 days + entinostat 4 mg/m²/d on day 3 and day 10
Trial: 16834487
Drug: Selective DA
RxNorm normalized name: DAS-181
DrugBank: DAS-181 (DB15313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective DA D2 receptor antagonist
Trial: 28722627
Drug: Rapid Diagnostic
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid Diagnostic Tests (RDTs) performed by Community Health Workers (CHWs) for malaria screening and treatment with artemether‐lumefantrine.
Trial: 19466436
Drug: Complex cream
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex cream
Trial: 31894491
Drug: Teriparatide followed
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide followed by alendronate (once-weekly subcutaneous injections of teriparatide 56.5 μg for 72 weeks followed by alendronate for 48 weeks)
Trial: 31894491
Drug: Alendronate monotherapy
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate monotherapy (alendronate for 120 weeks)
Trial: 18470667
Drug: Alendronate monotherapy
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate monotherapy
Trial: 30509312
Drug: Pembrolizumab (anti-PD-1)
RxNorm normalized name: Anti-PD-1 monoclonal antibody MGA012
DrugBank: Pembrolizumab (DB09037)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pembrolizumab (anti-PD-1) plus chemotherapy
Trial: 20028833
Drug: 12-week cognitive
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week cognitive behavior therapy program for hostility reduction
Trial: 6312461
Drug: pivampicillin alone
RxNorm normalized name: pivampicillin
DrugBank: Pivampicillin (DB01604)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivampicillin alone (250 mg pivampicillin 3-times daily for 7 to 14 days)
Trial: 9097275
Drug: Interferon-alpha treatment
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha treatment for 6 months (Group I)
Trial: 9097275
Drug: Interferon-alpha treatment
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha treatment for both groups
Trial: 22302034
Drug: γ-secretase modulator
RxNorm normalized name: gonorrheal urethral secretion human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ-secretase modulator E2012
Trial: 8899080
Drug: Butyrate enemas
RxNorm normalized name: butyrate
DrugBank: Butyric Acid (DB03568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butyrate enemas (60 mL of 80 mM sodium butyrate)
Trial: 8153771
Drug: Cefotaxime 500
RxNorm normalized name: cefotaxime 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 500 mg
Trial: 18313556
Drug: Sequential designs
RxNorm normalized name: Designer Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential designs (group sequential designs, boundaries designs, adaptive designs)
Trial: 17201235
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of betamethasone
Trial: 1378139
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine sustained-release (SR)
Trial: 6357270
Drug: Weekly cardiotocography
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly cardiotocography (antenatal fetal heart rate monitoring)
Trial: 26742388
Drug: Liquid medication
RxNorm normalized name: Medicated Liquid Soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid medication
Trial: 29154054
Drug: Chamomile extract
RxNorm normalized name: Chamomile Extract
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile extract capsules (200mg) twice a day for 28 days
Trial: 29154054
Drug: Wheat flour
RxNorm normalized name: Wheat Flour
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat flour capsules (200mg) twice a day for 28 days (Control)
Trial: 21620309
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group attended a 30-minute educational session on safe use of over-the-counter medications.
Trial: 11777488
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (ORTHO EVRA/EVRA) applied 1/week for three cycles (3 weeks/cycle)
Trial: 15944559
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection (placebo)
Trial: 9107203
Drug: Process consultation
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Process consultation with nurse manager-consultant meetings (high-dose)
Trial: 22764197
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 µg daily for 12 weeks)
Trial: 21577221
Drug: Arbaclofen placarbil
RxNorm normalized name: Arbaclofen Placarbil
DrugBank: Arbaclofen Placarbil (DB08892)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arbaclofen placarbil (AP) 20 mg
Trial: 21577221
Drug: Combined Arbaclofen
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined Arbaclofen placarbil (AP) 20/30 mg
Trial: 16814131
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy (HRT) with continuous transdermal estradiol patch (36 microg/day) plus cyclic oral medroxyprogesterone acetate (MPA; 2.5 mg/day for 12 days) for 12 months
Trial: 17283312
Drug: Controlled-release carbamazepine
RxNorm normalized name: carbamazepine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release carbamazepine (200 mg twice daily)
Trial: 22704112
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ubiquinol daily for 26 weeks
Trial: 22118754
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g fructose and 33.3 g erythritol
Trial: 22118754
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g fructose and 50 g glucose
Trial: 22118754
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g fructose alone
Trial: 26182832
Drug: CXCR2 antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CXCR2 antagonist AZD5069 (100 mg), twice daily orally for 6 days
Trial: 26182832
Drug: CXCR2 antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CXCR2 antagonist AZD5069 (100 mg)
Trial: 24377096
Drug: Multilayered Compression
RxNorm normalized name: zileuton
DrugBank: Zileuton (DB00744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multilayered Compression Therapy (MCT), n = 23
Trial: 3301458
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (550 mg initially, 275 mg every 6 h thereafter)
Trial: 23301475
Drug: Auricular point
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular point sticking with vaccaria seed at Endocrine (CO18), Mammary Gland, etc., pressed 3 times daily for 1-2 min each time
Trial: 319006
Drug: Atenolol 3
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol 3 mg intravenous
Trial: 27220675
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol with 600 mg of Mg sulfate
Trial: 23328380
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of GlideScope and fiberoptic bronchoscope (G+F)
Trial: 18663331
Drug: Monthly dietetic
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly dietetic consultations for 6 months
Trial: 23652751
Drug: Etoricoxib treatment
RxNorm normalized name: etoricoxib
DrugBank: Etoricoxib (DB01628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib treatment
Trial: 9433650
Drug: Single and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single and repeat doses of grepafloxacin
Trial: 15002680
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to substance abuse treatment
Trial: 15002680
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to substance abuse and mental health treatment
Trial: 19447479
Drug: 12 monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 12 monthly cycles of paclitaxel (175 mg/m2 over 3 h)
Trial: 19447479
Drug: 3 monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3 monthly cycles of paclitaxel (175 mg/m2 over 3 h)
Trial: 4020569
Drug: Traditional oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional oral fluid replacement (sodium 35 mmol/L)
Trial: 15018852
Drug: Famciclovir 750
RxNorm normalized name: famciclovir 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 750 mg once daily
Trial: 21784047
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (400 mg iron daily for 4 months)
Trial: 31475798
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aspirin
Trial: 10099053
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ebastine (elderly)
Trial: 28544600
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (30 mg/kg in 5 min)
Trial: 20456486
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg acetylsalicylic acid daily for 7 days
Trial: 3392421
Drug: Killed whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed whole cell (WC) oral cholera vaccine
Trial: 20861135
Drug: G-CSF 5
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF 5 μg/kg b.i.d. subcutaneously for 5 days
Trial: 7502115
Drug: MiniMed implantable
RxNorm normalized name: homatropine hydrobromide Ophthalmic Solution [Minims Homatropine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MiniMed implantable insulin pump (MIP)
Trial: 18315451
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 500 to 1500 mg b.i.d.
Trial: 31472087
Drug: Alveolar ridge
RxNorm normalized name: BLUE RIDGE BLUEBERRY
DrugBank: Blueberry (DB10629)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alveolar ridge preservation with adjunctive use of enamel matrix derivative (EMD)
Trial: 7937278
Drug: Isoniazid tablets
RxNorm normalized name: Isoniazid Tablets
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid tablets 300 mg
Trial: 21842241
Drug: Combination PPI
RxNorm normalized name: PPI-1040
DrugBank: PPI-1040 (DB17620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination PPI plus rebamipide
Trial: 19277410
Drug: Manual dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual dosage by experienced medical staff
Trial: 9853542
Drug: Beta-carotene (betaC)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (betaC) supplementation (30 mg daily)
Trial: 30573480
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with an ACE inhibitor (perindopril) and a beta-blocker (bisoprolol)
Trial: 21063906
Drug: Corn gluten
RxNorm normalized name: AMINO ACIDS, CORN GLUTEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn gluten meal (CGM) at 100 g kg⁻¹
Trial: 26355170
Drug: Augmented group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented group with longer implants (at least 11.5 mm)
Trial: 1490666
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with rhGH (2.6 IU/m2 daily) and oxandrolone (0.1 mg/kg body weight orally)
Trial: 16750207
Drug: Estradiol treatment
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol treatment
Trial: 2852792
Drug: Rhesus rotavirus
RxNorm normalized name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension [Rotarix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhesus rotavirus vaccine (MMU-18006)
Trial: 20736449
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg daily for 14 days
Trial: 29923478
Drug: Weekly 8-session
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly 8-session worry intervention group (n = 7)
Trial: 2609991
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg thrice daily
Trial: 24445356
Drug: Injection therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection therapy
Trial: 20441717
Drug: Olanzapine ODT
RxNorm normalized name: Olanzapine Orally Disintegrating Tablets
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine ODT (10 mg od, 8 days)
Trial: 15828904
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium carbonate alone
Trial: 15828904
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium carbonate plus vitamin D sterol
Trial: 21226886
Drug: Control (independent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (independent of drug use)
Trial: 17006875
Drug: Donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 5 mg immediately following surgery and every 24 h for a further three days
Trial: 11268298
Drug: Hormone-based therapies
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone-based therapies (progestins, androgens, GnRH analogs)
Trial: 8501340
Drug: Clofazimine 50
RxNorm normalized name: clofazimine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofazimine 50 mg daily
Trial: 25170226
Drug: 250 mg/d
RxNorm normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/d PI-88
Trial: 25985038
Drug: Epinephrine solution
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine solution (control)
Trial: 27175680
Drug: Fentanyl 20
RxNorm normalized name: fentaNYL 200 mcg buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 20 μg/kg diluted to 100 mL in 0.9% saline
Trial: 27118812
Drug: C-reactive protein
RxNorm normalized name: C-reactive protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-reactive protein (CRP) >10 mg/L
Trial: 11434597
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha (IFN-α) with ribavirin (approximately 14 mg/kg/day for 3 months)
Trial: 9197945
Drug: RP 60180
RxNorm normalized name: RP-72
DrugBank: RP-72 (DB17156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RP 60180 (1.0 mg)
Trial: 21368592
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor
Trial: 24020899
Drug: pioglitazone 45
RxNorm normalized name: pioglitazone 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone 45 mg daily
Trial: 21949991
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg ginaton by vein, once a day for 14 days (Group A)
Trial: 21601481
Drug: Target Hb
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Target Hb value in subnormal range (110‐129 g/l), group 1, n=43
Trial: 28818518
Drug: Seladelpar 50
RxNorm normalized name: Seladelpar
DrugBank: Seladelpar (DB12390)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seladelpar 50 mg/day
Trial: 28818518
Drug: Seladelpar 200
RxNorm normalized name: Seladelpar
DrugBank: Seladelpar (DB12390)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seladelpar 200 mg/day
Trial: 20638563
Drug: Diclofenac slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac slow release 75 mg twice a day plus omeprazole 20 mg once a day
Trial: 23530709
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg once daily